Early Hepatitis B Surface Antigen Seroclearance Following Antiviral Treatment in Patients with Reactivation of Resolved Hepatitis B-Reference-Cited by-同舟云学术

Early Hepatitis B Surface Antigen Seroclearance Following Antiviral Treatment in Patients with Reactivation of Resolved Hepatitis B

Published:2019-04-13 Issue:10 Volume:64 Page:2992-3000
ISSN:0163-2116
Container-title:Digestive Diseases and Sciences
language:en
Short-container-title:Dig Dis Sci

Author:

Lee Hae Lim,Jang Jeong Won,Han Ji Won,Lee Sung Won,Bae Si Hyun,Choi Jong Young,Han Nam Ik,Yoon Seung Kew,Kim Hee-Je,Lee Seok,Cho Seok-Goo,Min Chang-Ki,Kim Dong-Wook,Lee Jong Wook

Funder

the Ministry of Science, ICT & Future Planning

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Physiology

Link

http://link.springer.com/content/pdf/10.1007/s10620-019-05614-6.pdf

Reference29 articles.

1. Yeo W, Chan TC, Leung NW, et al. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab. J Clin Oncol. 2009;27:605–611.

2. Hsu C, Tsou HH, Lin SJ, et al. Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: a prospective study. Hepatology. 2014;59:2092–2100.

3. Han JW, Yang H, Lee HL, et al. Risk factors and outcomes of hepatitis B virus reactivation in hepatitis B surface antigen negative patients with hematological malignancies. Hepatol Res. 2015;46:657–668.

4. Jang JW, Kim YW, Lee SW, et al. Reactivation of hepatitis B virus in HBsAg-negative patients with hepatocellular carcinoma. PLoS ONE. 2015;10:e0122041.

5. Seto WK. Hepatitis B virus reactivation during immunosuppressive therapy: appropriate risk stratification. World J Hepatol. 2015;7:825–830.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. KASL clinical practice guidelines for management of chronic hepatitis B;Clinical and Molecular Hepatology;2022-04-01

2. Effectiveness of prophylactic antiviral therapy in reducing HBV reactivation for HBsAg-positive recipients following allogeneic hematopoietic stem cell transplantation: a multi-institutional experience from an HBV endemic area;Annals of Hematology;2022-01-04

3. Hepatitis B Virus Infection in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation;Journal of Personalized Medicine;2021-10-28

4. Long-Term Safety of Rituximab (Risks of Viral and Opportunistic Infections);Current Rheumatology Reports;2021-07-16

5. Reactivation of Resolved Hepatitis B After Daratumumab for Multiple Myeloma;Clinical Infectious Diseases;2021-04-12